Non-Acidified MMS: Medical - type patents describe the use of stabilised sodium chlorite in oral, topical and intravenous applications for treating
autoimmune diseases and chronic infections, also
hepatitis and lymphoma, and for neutralising the neuro - toxic effects of acetaldehyde produced
by Candida and other fungi.